322 related articles for article (PubMed ID: 24119686)
1. Routine versus selective cardiac magnetic resonance in non-ischemic heart failure - OUTSMART-HF: study protocol for a randomized controlled trial (IMAGE-HF (heart failure) project 1-B).
Paterson I; Wells GA; Ezekowitz JA; White JA; Friedrich MG; Mielniczuk LM; O'Meara E; Chow B; DeKemp RA; Klein R; Dennie C; Dick A; Coyle D; Dwivedi G; Rajda M; Wright GA; Laine M; Hanninen H; Larose E; Connelly KA; Leong-Poi H; Howarth AG; Davies RA; Duchesne L; Yla-Herttuala S; Saraste A; Farand P; Garrard L; Tardif JC; Arnold M; Knuuti J; Beanlands R; Chan KL
Trials; 2013 Oct; 14():332. PubMed ID: 24119686
[TBL] [Abstract][Full Text] [Related]
2. OUTSMART HF: A Randomized Controlled Trial of Routine Versus Selective Cardiac Magnetic Resonance for Patients With Nonischemic Heart Failure (IMAGE-HF 1B).
Paterson DI; Wells G; Erthal F; Mielniczuk L; O'Meara E; White J; Connelly KA; Knuuti J; Radja M; Laine M; Chow BJW; Kandolin R; Chen L; Dick A; Dennie C; Garrard L; Ezekowitz J; Beanlands R; Chan KL;
Circulation; 2020 Mar; 141(10):818-827. PubMed ID: 31910649
[TBL] [Abstract][Full Text] [Related]
3. Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) IMAGE HF Project I-A: study protocol for a randomized controlled trial.
O'Meara E; Mielniczuk LM; Wells GA; deKemp RA; Klein R; Coyle D; Mc Ardle B; Paterson I; White JA; Arnold M; Friedrich MG; Larose E; Dick A; Chow B; Dennie C; Haddad H; Ruddy T; Ukkonen H; Wisenberg G; Cantin B; Pibarot P; Freeman M; Turcotte E; Connelly K; Clarke J; Williams K; Racine N; Garrard L; Tardif JC; DaSilva J; Knuuti J; Beanlands R;
Trials; 2013 Jul; 14():218. PubMed ID: 23866673
[TBL] [Abstract][Full Text] [Related]
4. Impact of cardiac magnetic resonance imaging on heart failure patients referred to a tertiary advanced heart failure unit: improvements in diagnosis and management.
Lum YH; McKenzie S; Brown M; Hamilton-Craig C
Intern Med J; 2019 Feb; 49(2):203-211. PubMed ID: 30152581
[TBL] [Abstract][Full Text] [Related]
5. Role of cardiac magnetic resonance in heart failure of initially unknown etiology: A 10-year observational study.
Ojrzyńska-Witek N; Marczak M; Mazurkiewicz Ł; Petryka-Mazurkiewicz J; Miłosz-Wieczorek B; Grzybowski J; Śpiewak M
Kardiol Pol; 2022; 80(3):278-285. PubMed ID: 34936084
[TBL] [Abstract][Full Text] [Related]
6. Direct comparison of the diagnostic capability of cardiac magnetic resonance and endomyocardial biopsy in patients with heart failure.
Yoshida A; Ishibashi-Ueda H; Yamada N; Kanzaki H; Hasegawa T; Takahama H; Amaki M; Asakura M; Kitakaze M
Eur J Heart Fail; 2013 Feb; 15(2):166-75. PubMed ID: 23329703
[TBL] [Abstract][Full Text] [Related]
7. Role of cardiovascular magnetic resonance as a gatekeeper to invasive coronary angiography in patients presenting with heart failure of unknown etiology.
Assomull RG; Shakespeare C; Kalra PR; Lloyd G; Gulati A; Strange J; Bradlow WM; Lyne J; Keegan J; Poole-Wilson P; Cowie MR; Pennell DJ; Prasad SK
Circulation; 2011 Sep; 124(12):1351-60. PubMed ID: 21900085
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Pulmonary Transit Time by Cardiac Magnetic Resonance on Mortality and Heart Failure Hospitalization in Patients With Advanced Heart Failure and Reduced Ejection Fraction.
Houard L; Amzulescu MS; Colin G; Langet H; Militaru S; Rousseau MF; Ahn SA; Vanoverschelde JJ; Pouleur AC; Gerber BL
Circ Cardiovasc Imaging; 2021 Jan; 14(1):e011680. PubMed ID: 33438438
[TBL] [Abstract][Full Text] [Related]
9. Impact of Cardiovascular Magnetic Resonance Imaging on Identifying the Etiology of Cardiomyopathy in Patients Undergoing Cardiac Transplantation.
Lin LQ; Kazmirczak F; Chen KA; Okasha O; Nijjar PS; Martin CM; Akçakaya M; Farzaneh-Far A; Shenoy C
Sci Rep; 2018 Nov; 8(1):16212. PubMed ID: 30385862
[TBL] [Abstract][Full Text] [Related]
10. Point-of-care B-type natriuretic peptide and portable echocardiography for assessment of patients with suspected heart failure in primary care: rationale and design of the three-part Handheld-BNP program and results of the training study.
Morbach C; Buck T; Rost C; Peter S; Günther S; Störk S; Prettin C; Erbel R; Ertl G; Angermann CE;
Clin Res Cardiol; 2018 Feb; 107(2):95-107. PubMed ID: 29143161
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and cost-effectiveness of serum B-type natriuretic peptide testing and monitoring in patients with heart failure in primary and secondary care: an evidence synthesis, cohort study and cost-effectiveness model.
Pufulete M; Maishman R; Dabner L; Mohiuddin S; Hollingworth W; Rogers CA; Higgins J; Dayer M; Macleod J; Purdy S; McDonagh T; Nightingale A; Williams R; Reeves BC
Health Technol Assess; 2017 Aug; 21(40):1-150. PubMed ID: 28774374
[TBL] [Abstract][Full Text] [Related]
12. A remote monitoring and telephone nurse coaching intervention to reduce readmissions among patients with heart failure: study protocol for the Better Effectiveness After Transition - Heart Failure (BEAT-HF) randomized controlled trial.
Black JT; Romano PS; Sadeghi B; Auerbach AD; Ganiats TG; Greenfield S; Kaplan SH; Ong MK;
Trials; 2014 Apr; 15():124. PubMed ID: 24725308
[TBL] [Abstract][Full Text] [Related]
13. [The role of cardiovascular magnetic resonance imaging in the diagnosis and prognosis of patients with heart failure].
Hombach V; Merkle N; Rasche V; Bernhardt P; Rottbauer W
Herz; 2011 Mar; 36(2):84-93. PubMed ID: 21424346
[TBL] [Abstract][Full Text] [Related]
14. CarDiac MagnEtic Resonance for Primary Prevention Implantable CardioVerter DebrillAtor ThErapy international registry: Design and rationale of the DERIVATE study.
Guaricci AI; Masci PG; Lorenzoni V; Schwitter J; Pontone G
Int J Cardiol; 2018 Jun; 261():223-227. PubMed ID: 29550015
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of heart failure in hemodialysis-dependent end-stage renal disease patients with myocardial fibrosis quantification by extracellular volume on cardiac magnetic resonance imaging.
Xu HY; Yang ZG; Zhang Y; Peng WL; Xia CC; Li ZL; He Y; Xu R; Rao L; Peng Y; Li YM; Gao HL; Guo YK
BMC Cardiovasc Disord; 2020 Jan; 20(1):12. PubMed ID: 31924159
[TBL] [Abstract][Full Text] [Related]
16. Additional Prognostic Value of 2D Right Ventricular Speckle-Tracking Strain for Prediction of Survival in Heart Failure and Reduced Ejection Fraction: A Comparative Study With Cardiac Magnetic Resonance.
Houard L; Benaets MB; de Meester de Ravenstein C; Rousseau MF; Ahn SA; Amzulescu MS; Roy C; Slimani A; Vancraeynest D; Pasquet A; Vanoverschelde JJ; Pouleur AC; Gerber BL
JACC Cardiovasc Imaging; 2019 Dec; 12(12):2373-2385. PubMed ID: 30772232
[TBL] [Abstract][Full Text] [Related]
17. Imaging heart failure: current and future applications.
Paterson I; Mielniczuk LM; O'Meara E; So A; White JA
Can J Cardiol; 2013 Mar; 29(3):317-28. PubMed ID: 23439018
[TBL] [Abstract][Full Text] [Related]
18. Identification of the ischemic etiology of heart failure by cardiovascular magnetic resonance imaging: diagnostic accuracy of late gadolinium enhancement.
Casolo G; Minneci S; Manta R; Sulla A; Del Meglio J; Rega L; Gensini G
Am Heart J; 2006 Jan; 151(1):101-8. PubMed ID: 16368300
[TBL] [Abstract][Full Text] [Related]
19. Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the "Cardiac Benefits" of Empagliflozin Independent of its Hypoglycemic Activity?
Santos-Gallego CG; Garcia-Ropero A; Mancini D; Pinney SP; Contreras JP; Fergus I; Abascal V; Moreno P; Atallah-Lajam F; Tamler R; Lala A; Sanz J; Fuster V; Badimon JJ
Cardiovasc Drugs Ther; 2019 Feb; 33(1):87-95. PubMed ID: 30675708
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
